Page last updated: 2024-09-03

1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone and cephalexin

1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone has been researched along with cephalexin in 1 studies

Compound Research Comparison

Studies
(1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone)
Trials
(1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone)
Recent Studies (post-2010)
(1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone)
Studies
(cephalexin)
Trials
(cephalexin)
Recent Studies (post-2010) (cephalexin)
23102,229338329

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corsiero, D; Girbig, F; Glombik, H; Heuer, H; Kramer, W; Petry, S; Schäfer, H; Wendler, W; Weyland, C1

Other Studies

1 other study(ies) available for 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone and cephalexin

ArticleYear
Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter.
    FEBS letters, 2000, Dec-29, Volume: 487, Issue:2

    Topics: Animals; Anticholesteremic Agents; Azetidines; Bile Acids and Salts; Carrier Proteins; Cephalexin; Cholesterol; Drug Design; Ezetimibe; Fatty Acids; Glucose; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Microvilli; Rabbits; Structure-Activity Relationship

2000